On June 11, Cerebras Systems fell 3.26% in regular trading, trading at $232.4/share, with trading volume of $197 million. The decline came as earlier gains driven by a wave of Wall Street initiations were digested, triggering renewed profit-taking pressure.
Multiple top-tier investment banks recently initiated coverage with bullish ratings: Citi assigned a Buy rating with a $340 target, UBS initiated at Buy with a $300 target, Craig-Hallum set a Buy rating with a $325 target, Barclays rated the stock Overweight with a $280 target, and Morgan Stanley initiated at Overweight with a $250 target. These catalysts had previously propelled shares to approximately $241, but with the upside momentum fully priced in, selling pressure from profit-taking has re-emerged.
Additionally, following the completion of the S&P index inclusion in late May, the stock has been in a corrective trend. The company's price-to-sales ratio remains well above industry averages post-IPO, and elevated valuations continue to face headwinds in the current interest rate environment.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments